DaVita, Inc. http://www.alacrastore.com/company-snapshot/DaVita_Inc-1075959 Tuesday, October 14, 2008 9:40:26 AM 1075959 DaVita, Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/BW-0001-28690340newstex/BW-0001-28690340xml Oct. ##, #### (Business Wire) -- DaVita Inc. (NYSE:DVA) has revised the time of its Q# #### quarterly conference call, the date remains unchanged. This call is also being webcast and can be accessed at the DaVita IR web page or over...0400000004016000040160180401604810/13/2008 9:24:47 AM180000001800400018008000Business WireBW-0001-28690340DAVITA INCDVANewsNewstexhttp://www.alacrastore.com/storecontent/moodys/PBC_96131moodys/PBC_96131pdf...On the heels of new management in ####, DaVita overhauled its board and its governance practices. DaVita sought new directors with experience specifically applicable to the company s needs and established a framework of oversight and compliance policies that could evolve into a corporate culture of compliance and risk management. With an essentially new slate of directors added over the last five years, each bringing very appropriate background, important governance practices such as executive sessions (meetings of outside directors with company managers excluded) and a separate hot-line were in place before required. Importantly, and perhaps in recognition of some historical lack of adequate oversight prior to current management, DaVita established a chief compliance officer to implement and manage the compliance policies. The chief compliance officer has a reporting relationship to the compliance committee. Nonetheless, we believe DaVita s relatively small board could be challenged... 10/4/2008 8:29:50 PMpdfDaVita, Inc.DaVita, Inc.600037744300.00AnalysisCorporate Governance AssmtPBC_96131Credit & Investment ResearchMoody's Global Credit Researchhttp://www.alacrastore.com/storecontent/spcred/673072spcred/673072normThe latest Full Report from S&Pglobalstructured9/24/2008 1:16:38 PM400Full Report673072United StatesHealth Care ServicesEmerging MarketsLatin AmericaUnited StatesGlobal IssuersStructured FinanceCorporationsAsset-Backed SecuritiesHealth CareFull ReportLeading U.S. market position in an industry with solid growth prospects; Relatively predictable, recurring kidney dialysis revenues and cash flow; and Large, geographically diverse asset base, which provides leverage with suppliers and payors. Dependence on a single disease; Third-party reimbursement pressures; Cost containment pressures (will be more acute under Medicare bundled reimbursement beginning in 2011); Aggressive financial policy. The ratings on El Segundo, Calif.-based renal care company DaVita Inc. reflect the company's dependence on the treatment of a single disease, providing hemodialysis and ancillary services mainly on an outpatient basis, to those suffering from chronic kidney failure, rendering it vulnerable to cuts or insufficient increases in third-party reimbursement rates. The ratings also reflect the company's cost-management challenges and DaVita's aggressiveUSA23918K89151B89151A75967123918V35102015 351020 3510 35DaVita Inc.129285EMERGINGLATAMERICAUSADVAFULLGLOBISSSTRUCCORPABSHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/673074spcred/673074normThe latest Summary from S&Pglobalstructured9/24/2008 1:16:38 PM175Summary673074United StatesHealth Care ServicesEmerging MarketsLatin AmericaUnited StatesGlobal IssuersStructured FinanceCorporationsAsset-Backed SecuritiesHealth CareSummaryThe ratings on El Segundo, Calif.-based renal care company DaVita Inc. reflect the company's dependence on the treatment of a single disease, providing hemodialysis and ancillary services mainly on an outpatient basis to those suffering from chronic kidney failure, rendering it vulnerable to cuts or insufficient increases in third-party reimbursement rates. The ratings also reflect the company's cost-management challenges and DaVita's aggressive financial policies. These factors are partly offset by the stabilizing effects of the company's recurring revenue stream, its large clinic network with a leading U.S. market position, and its attractive growth prospects. Government (predominantly Medicare) reimbursement accounts for about 65% of the company's revenues, with commercial payors providing the remainder. This leaves DaVita vulnerable to third-party reimbursement changes.USA23918K89151B89151A75967123918V35102015 351020 3510 35DaVita Inc.129285EMERGINGLATAMERICAUSADVASUMMARYGLOBISSSTRUCCORPABSHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/newstex/BW-0001-28193143newstex/BW-0001-28193143xml Sep. ##, #### (Business Wire) -- DaVita Inc. (NYSE:DVA) announced today that it will hold its quarterly conference call to discuss third quarter results on Monday, November #, #### at # PM Eastern. The Company plans to release its...04000000040160000401600104016048040160189/19/2008 5:19:39 PM180000001800400018008000Business WireBW-0001-28193143DAVITA INCDVANewsNewstexhttp://www.alacrastore.com/storecontent/fitch/397888_report_framefitch/397888_report_framepdfFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Building Materials Holdings CorporationCablevision SADaVita, Inc.Del Monte Foods CompanyPeabody Energy CorporationStar Gas Partners, L.P.8009028680091642803608838046438081841380819721268/22/2008 6:32:00 PM010200000103000001030100010307000103090001031200010312020103170001040000275NewsletterBLGBTUDLMDVASGU397888_report_frameCredit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/fitch/430313_pr_framefitch/430313_pr_framehtmlFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.DaVita, Inc.818413808/21/2008 6:34:00 PM010300000103170085Press ReleaseDVA430313_pr_frameCredit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/ccbn/B1884070ccbn/B1884070norm...DVA expects #### operating income to be $###-###m and #### operating income to be $###-###m. www.streetevents.comContact Us ... 8/4/2008 8:05:00 PMDaVita54.0000EditedDaVita Q2 2008 Earnings Conference Call SummaryDVA5:00pm ETBriefB1884070Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1884070ccbn/T1884070norm...Good afternoon. I'll be your conference operator today. At this time I'd like to welcome everyone to the DaVita second quarter earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks there'll be a question-and-answer session. (OPERATOR INSTRUCTIONS) Thank you, Ms. Zumwalt you may begin your conference. ... 8/4/2008 7:05:00 PMDaVita54.0000FinalDaVita Q2 2008 Earnings Conference Call TranscriptDVA5:00pm ETTranscriptT1884070Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-27155375newstex/PRN-0005-27155375xml EL SEGUNDO, Calif., Aug. #, #### (PRNewswire-FirstCall delivered by Newstex) -- DaVita Inc. (NYSE: DVA) today announced results for the quarter ended June ##, ####. Net income for the three and six months ended June ##, #### was $##.#...11000000110020001400000014010000040000000401600004016048040160180401600304016001040020000400200604006000040060058/4/2008 5:19:00 PM1800000018004000180080001900000019001000PR Newswire USPRN-0005-27155375DAVITA INCDVANewsNewstexhttp://www.alacrastore.com/storecontent/fitch/393346_report_framefitch/393346_report_framepdfFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Schering-Plough CorporationLifepoint Hospitals, Inc.HCA Inc.Medco Health Solutions, IncMcKesson CorporationCommunity Health Systems, Inc.Watson Pharmaceuticals, Inc.Tenet Healthcare CorporationDaVita, Inc.Health Management Associates, Inc.Universal Health Services, Inc.Cardinal Health, Inc.Thermo Fisher Scientific IncBoston Scientific CorporationOwens & Minor, Inc.AmerisourceBergen CorporationExpress Scripts, Inc.800900878008936881683472800920878160965581841365800906288184138080089369800911138009116682953125800902068008952681683499800915911010000132807104107/16/2008 6:31:00 PM010300000104000001031700030204000103170201031703275Special ReportCYHMHSUHSABCMCKSGPHMALPNTTHCOMITMOCAHBSXWPIESRXDVA393346_report_frameCredit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/fitch/392588_report_framefitch/392588_report_framepdfFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.DaVita, Inc.818413807/10/2008 10:14:00 AM0103170001030000425Full Rating ReportDVA392588_report_frameCredit & Investment ResearchFitch ResearchUS - In May ####, the board of DaVita Inc, a provider of dialysis and healthcare related services, authorized the repurchase of up to $### mil of the company's common stock outstanding in open market or privately negotiated transactions.5/9/2008 1:23:19 PM23918K23918K23918K23918KDaVita IncDaVita IncDaVita IncDaVita Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/DaVita_Inc_buys_back_stock-1976173020sdc/19761730201976173020Copyright © 2008, Thomson Financial, All Rights ReservedNew YorkHealth ServicesUnited StatesKidney dialysis centers8092CACaliforniaPublicDVA8092:Kidney dialysis centers8092:Kidney dialysis centersNew YorkHealth ServicesUnited StatesKidney dialysis centers8092CACaliforniaPublicDVA341154002Pvd kidney dialysis svcsPvd kidney dialysis svcsCashCash OnlyCommon Stock341154002May 9 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.0000018.0000019.00000DaVita Inc, located in ElSegundo, California, providesdialysis and healthcarerelated services for patientssuffering from chronic kidneyfailure. The company operates1,300 outpatient dialysiscenters in 42 states and theDistrict of Columbi, servingapproximately 103,000patients. The company alsoprovides a range of ancillaryservices to ESRD patients,including EPO and otherpharmaceuticals, ESRDlaboratory services and ESRDclinical research programs.The company was founded in1994.DaVita Inc, located in El Segundo, California, providesdialysis and healthcare related services for patientssuffering from chronic kidney failure. The company operates1,300 outpatient dialysis centers in 42 states and theDistrict of Columbi, serving approximately 103,000 patients.The company also provides a range of ancillary services toESRD patients, including EPO and other pharmaceuticals, ESRDlaboratory services and ESRD clinical research programs. Thecompany was founded in 1994.DaVita Inc, located in El Segundo, California, provides dialysis and healthcare related services for patients suffering from chronic kidney failure. The company operates 1,300 outpatient dialysis centers in 42 states and the District of Columbi, serving approximately 103,000 patients. The company also provides a range of ancillary services to ESRD patients, including EPO and other pharmaceuticals, ESRD laboratory services and ESRD clinical research programs. The company was founded in 1994.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.0000018.0000019.00000DaVita Inc, located in ElSegundo, California, providesdialysis and healthcarerelated services for patientssuffering from chronic kidneyfailure. The company operates1,300 outpatient dialysiscenters in 42 states and theDistrict of Columbi, servingapproximately 103,000patients. The company alsoprovides a range of ancillaryservices to ESRD patients,including EPO and otherpharmaceuticals, ESRDlaboratory services and ESRDclinical research programs.The company was founded in1994.DaVita Inc, located in El Segundo, California, providesdialysis and healthcare related services for patientssuffering from chronic kidney failure. The company operates1,300 outpatient dialysis centers in 42 states and theDistrict of Columbi, serving approximately 103,000 patients.The company also provides a range of ancillary services toESRD patients, including EPO and other pharmaceuticals, ESRDlaboratory services and ESRD clinical research programs. Thecompany was founded in 1994.DaVita Inc, located in El Segundo, California, provides dialysis and healthcare related services for patients suffering from chronic kidney failure. The company operates 1,300 outpatient dialysis centers in 42 states and the District of Columbi, serving approximately 103,000 patients. The company also provides a range of ancillary services to ESRD patients, including EPO and other pharmaceuticals, ESRD laboratory services and ESRD clinical research programs. The company was founded in 1994.0.000000.000000.00000104.70000NU.S. Dollar07 May 08Wed, 07 May 2008 00:00:00 ESTDate Announced: 05/07/2008Date Effective:BuybackNot Appl.0.000000.000000.000000.000000.000000.00000Price/Share0.00000250 U.S. Dollar250.000000.00000250 U.S. Dollar250.000000.000000.000000.000000.00000250.00000250 U.S. Dollar1.00000N126.704000.000000.000000.000000.000000.00000250.00000250.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.00000US - In May 2008, the board ofDaVita Inc, a provider ofdialysis and healthcarerelated services, authorizedthe repurchase of up to $250mil of the company's commonstock outstanding in openmarket or privately negotiatedtransactions.US - In May 2008, the board of DaVita Inc, a provider of dialysis and healthcare related services, authorized the repurchase of up to $250 mil of the company's common stock outstanding in open market or privately negotiated transactions.US - In May 2008, the board of DaVita Inc, a provider of dialysis and healthcare relatedservices, authorized the repurchase of up to $250 mil of the company's common stockoutstanding in open market or privately negotiated transactions.US - In May 2008, the board of DaVita Inc, a provider of dialysis and healthcare related services, authorized the repurchase of up to $250 mil of the company's common stock outstanding in open marketor privately negotiated transactions.US - In May 2008, the board of DaVita Inc, a provider of dialysis and healthcare related services, authorized the repurchase of up to$250 mil of the company's common stock outstanding in open market or privately negotiated transactions.Intended0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Intended-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000008092:Kidney dialysis centers341154002New YorkUnited States8092CaliforniaPublicDVA8092:Kidney dialysis centers341154002New YorkUnited States8092CaliforniaPublicDVA250.00000250.00000250.00000126.70400Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/ccbn/T1812366ccbn/T1812366norm...Good afternoon. I'll be your conference operator today. At this time, I'd like to welcome everyone to the DaVita Q# earnings call. (OPERATOR INSTRUCTIONS) You may begins your conference. ... 4/29/2008 6:06:00 PMDaVita54.0000FinalQ1 2008 DaVita Earnings Conference Call TranscriptDVA4:30pm ETTranscriptT1812366Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B1812366ccbn/B1812366norm...In each of the aforementioned clinical measures, Co.'s outcomes compared quite favorably in national averages.... 4/29/2008 6:06:00 PMDaVita54.0000EditedQ1 2008 DaVita Earnings Conference Call SummaryDVA4:30pm ETBriefB1812366Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/spcred/640259spcred/640259normThe latest Summary from S&P3/31/2008 6:34:38 PMSummary175globalstructured640259United StatesHealth Care ServicesEmerging MarketsLatin AmericaUnited StatesGlobal IssuersStructured FinanceCorporationsAsset-Backed SecuritiesHealth CareSummaryThe ratings on El Segundo, Calif.-based renal care company DaVita Inc. reflect the company's dependence on the treatment of a single disease, rendering it vulnerable to cuts or insufficient increases in third-party reimbursement rates. The ratings also reflect the company's cost-management challenges and DaVita's aggressive financial policies. These factors are partly offset by the stabilizing effects of the company's recurring revenue stream, its large clinic network with a leading U.S. market position, and its attractive growth prospects. DaVita owns and operates approximately 1,360 dialysis centers throughout the U.S., providing hemodialysis and ancillary services, mainly on an outpatient basis, to those suffering from chronic kidney failure. DaVita also provides acute inpatient dialysis services. Government (predominantly Medicare) reimbursement accounts for about 60%USA23918K89151B89151A75967123918V35102015 351020 3510 35DaVita Inc.129285EMERGINGLATAMERICAUSADVASUMMARYGLOBISSSTRUCCORPABSHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/B1719847ccbn/B1719847normQ# #### DaVita Earnings Conference Call2/13/2008 9:06:00 PMDaVita54.0000EditedQ4 2007 DaVita Earnings Conference Call SummaryDVA5:00pm ETBriefB1719847Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1719847ccbn/T1719847normQ# #### DaVita Earnings Conference Call2/13/2008 7:06:00 PMDaVita54.0000FinalQ4 2007 DaVita Earnings Conference Call TranscriptDVA5:00pm ETTranscriptT1719847Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1733505ccbn/T1733505norm1/8/2008 5:05:00 PMDaVita54.0000FinalDaVita at JPMorgan Healthcare Conference TranscriptDVA9:00am PT... - JPMorgan - AnalystGood morning, ladies and gentlemen. Once again my name is Andreas Dirnagl, Senior Healthcare Services Analyst for JPMorgan and this morning I'm very pleased to be able to introduce DaVita. Representing DaVita is Chairman and CEO, Kent Thiry. DaVita, as many of you know, is one of the largest providers of dialysis services in the U.S. and therefore the world. And I will not try and interject anything and allow Kent the maximum amount of time that he has and with that I will turn it over to Kent with just a quick reminder that there will be a Q&A session with Kent and the rest of the DaVita team following this presentation in the Yorkshire room. Thank you. Kent?... TranscriptT1733505Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/fitch/343642_report_framefitch/343642_report_framepdf81841380813934548009159282176029AMTSPF80089000CCUStandard Pacific CorporationGeneral Motors Corporation8616610081201696R&G Financial CorporationDVAVolt Information SciencesFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.RGFC80091549Newsletter250GM8145947812/24/2007 11:15:41 AMClear Channel Communications, Inc.American Tower CorporationDaVita, Inc.VOL343642_report_frameCredit & Investment ResearchFitch Research